Search

everythinglearnresearchcommunity

for

Search:↓

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

New technologies show potential for better understanding and treating skin conditions with abnormal mucin, but more research is needed for clinical use.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

Common noncancerous skin diseases have various treatments, including topical applications, light therapy, surgery, and medications, with psychological support being important.

Autoimmune hepatitis in children often affects girls and can be treated successfully with medication.

Controlling immune responses with biomaterials can reduce scarring and improve skin regeneration.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

Patients need better information about the risks of long-term steroid use.

Immune therapy for cancer can cause hair loss scars in some patients.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

Most skin rashes in rheumatoid arthritis patients were not caused by their medication, and careful evaluation allowed most to keep taking their beneficial treatment.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Ulcerative colitis involves immune activation, chronic inflammation, and metabolic issues, some of which persist even during remission.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

People with alopecia areata often have abnormal thyroid hormones, thyroid antibodies, antinuclear antibodies, low vitamin D, and high C-reactive protein levels.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.

Consider DRIF and perform skin biopsies for persistent papular rashes.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Tacrolimus is effective for various skin conditions with fewer side effects than cyclosporine.

A 50-year-old woman with breast cancer developed an autoimmune skin disorder, highlighting the need for thorough checks and team-based treatment.

Managing skin diseases during pregnancy and postpartum requires careful consideration of treatment safety and dosing to protect both mother and baby.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Some drugs used to treat immune conditions may cause different types of hair loss.

High-dose vitamin D and an anti-inflammatory diet may help improve symptoms in autoimmune conditions like SLE and AA.